Last reviewed · How we verify
propofol, bupivacaine
At a glance
| Generic name | propofol, bupivacaine |
|---|---|
| Also known as | Fresofol, Marcaine |
| Sponsor | National Taiwan University Hospital |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Ultrasound Guided Pericapsular Nerve Block Versus iv Sedation Analgesia in Reduction of Shoulder Dislocation (PHASE2)
- General Anaesthesia vs Spinal Anaesthesia: Patient Outcomes and Success in Outpatient Primary Total Knee and Hip Arthroplasty (PHASE4)
- Low-Thoracic Epidural Anesthesia For Laparoscopic Nephrectomy. (NA)
- Perioperative Effects of Lateral Quadratus Lumborum Block in Percutaneous Transhepatic Cholangiography (NA)
- A Pilot Study of Local Anesthesia for Inguinal Hernia Surgery in Older Adults (NA)
- Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic Version (NA)
- GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries (PHASE3)
- Quality of Recovery After Laparoscopic Cholecystectomy Comparing Opioid Free Analgesia Versus Opioid Free Anesthesia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- propofol, bupivacaine CI brief — competitive landscape report
- propofol, bupivacaine updates RSS · CI watch RSS
- National Taiwan University Hospital portfolio CI